doc_id,table_id,row_index,ColumnA,ColumnB,ColumnC
WHO_TB_handbook_module6_comorbidities_2024,Table 3.3.,1,TB treatment regimens,Eligibility,Comments
WHO_TB_handbook_module6_comorbidities_2024,Table 3.3.,2,6-month rifampicin - based regimen: 2HRZE/4HR,Individuals with a new episode of pulmonary TB and extrapulmonary TB except for people with TB meningitis and osteoarticular TB,"Some expert groups suggest 9â€“12 months therapy for TB meningitis, and 9 months for osteoarticular TB"
WHO_TB_handbook_module6_comorbidities_2024,Table 3.3.,3,4-month moxifloxacin - based regimen: 2HPMZ/2HPM,People aged 12 years or older with drug-susceptible pulmonary TB and extrapulmonary TB,"Recommended for people living with HIV, except for the following groups (due to limited evidence): PLHIV on non-efavirenz-based regimens [a], PLHIV with a CD4 count < 100 cells/mm 2 , people weighing <40 kg, people with TB meningitis, disseminated TB, osteoarticular TB, abdominal TB, adolescents and children less than 12 years of age, pregnant, breastfeeding and postpartum women"